In this study, we found that PKM2 deregulation was a frequent event in the progression of TSCC and that PKM2 up-regulation was not only related to lymph node metastasis but also a prognostic factor in patients with TSCC. This evidence concerns the gene PKM and metastatic malignant neoplasm in the lymph nodes.